Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Man Group PLC Share Issue/Capital Change 2018

Dec 18, 2018

5182_rns_2018-12-18_cd28f57c-1541-4e08-a01e-51dcb38b25cc.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8852K

Man Group plc

18 December 2018

BLOCK LISTING SIX MONTHLY RETURN

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 18 December 2018

Name of applicant: Man Group plc
Name of schemes: 1.   2012 Partner Deferred Share Plan

2.   2012 Executive Share Option Plan

3.   Man Group 2012 Long-Term Incentive Plan

4.   Man Group 2012 Sharesave Scheme

5.   Man Group plc Partner Deferred Share Plan

6.   Man Group 2006 Long-Term Incentive Plan

7.   2011 Executive Share Option Plan

8.   GLG Partners, Inc. 2009 Long-Term Incentive Plan

9.   AHL Partners LLP Partner Deferred Share Plans

10.  Man GLG Partners LLP (formerly known as Laurel Heights LLP) Partner Deferred Share Plans
Period of return: From: 17 June 2018 To: 17 December 2018
Balance of unallotted securities under schemes from previous return: 10,542,439
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): nil
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 10,542,439
Name of contact: Rachel Rowson
Telephone number of contact: +44 (0) 207 144 1731

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRUWUNRWVAUAAA